Healthcare in other countries isn’t actually free. It’s prepaid through taxes or mandatory payroll contributions, then delivered to patients with little or no charge at the point of care. The difference isn’t that other nations found a way to eliminate costs. They chose to collect the money upfront and spread it across the entire population, rather than billing individuals when they get sick. The result looks free when you walk into a clinic, but the funding comes from somewhere specific.
How Countries Actually Pay for It
Universal healthcare systems generally fall into two broad categories, with most countries landing somewhere in between. The first is the tax-funded model, used by the United Kingdom, where the government collects general taxes and uses that revenue to run the health system directly. UK health spending has grown from 2.8% of GDP in the mid-1950s to 8.4% in 2022-23, making it the single largest area of government spending at nearly £1 out of every £5 the government spends. Patients pay nothing for doctor visits, hospital stays, or emergency care. The government is the payer, but it doesn’t necessarily employ every doctor or own every hospital.
The second model is social health insurance, used by Germany, France, and several other European countries. In Germany, employees and employers each pay half of a 14.6% contribution on gross wages into nonprofit “sickness funds.” Dependents, including nonearning spouses and children, are covered at no additional cost. The contributions are pooled centrally and redistributed to individual sickness funds using a formula that accounts for age, sex, and the burden of roughly 80 chronic and serious conditions. This means funds covering sicker populations get more money. On top of the base rate, each fund charges a supplementary contribution averaging about 1% of wages.
Canada takes a third approach: a single-payer system where provincial governments act as the sole insurer for medically necessary services. Doctors remain in private practice, but they bill the government instead of patients or insurance companies. The money comes from federal and provincial tax revenue.
What “Free” Actually Covers (and Doesn’t)
Even in universal systems, coverage has limits. Canada’s public insurance covers hospital care, physician services, and certain surgical-dental procedures. But prescription drugs, dental care, vision, chiropractic services, and ambulance rides are generally not included under the federal Canada Health Act. Provinces decide individually whether to cover these extras, and many target supplemental coverage toward children, seniors, or people receiving social assistance. Canadians who want broader coverage typically get it through employer-sponsored private insurance or pay out of pocket.
The UK’s National Health Service is more comprehensive, covering prescriptions (with a small fixed copay in England, free in Scotland and Wales), mental health services, and hospital care. Germany’s sickness funds cover a wide range of services but leave some gaps. Many Germans purchase supplementary private policies to cover things like private hospital rooms, certain copayments, or minor benefits outside the statutory package.
So “free healthcare” is really shorthand for a system where you won’t receive a bill for seeing your doctor, having surgery, or being treated for cancer. The taxes and payroll deductions that fund the system are ongoing costs, but they’re disconnected from the moment you actually need care. That separation is the key psychological and financial difference.
Why Drugs Cost Less in These Systems
One of the most visible differences between universal systems and the U.S. is prescription drug pricing. Countries with universal coverage negotiate drug prices at a national level, often before a new medication even reaches patients. In the UK, France, Germany, the Netherlands, Belgium, Canada, and Norway, independent agencies evaluate whether a new drug actually works better than existing treatments. That clinical assessment becomes leverage in price talks.
France negotiates contracts that tie prices to sales volume: as purchases increase, the price per unit drops. If sales exceed a specified cap, further reductions kick in automatically. The UK flags any drug expected to cost £20 million or more in its first three years for additional negotiations, even if it’s already been deemed cost-effective. France and Germany also use external reference pricing, comparing what other countries pay for the same drug to set their own ceiling. Germany requires manufacturers to submit pricing data from 15 other nations.
Nearly all of these countries also use managed entry agreements, which are essentially risk-sharing contracts between governments and pharmaceutical companies. These arrangements let patients access expensive new drugs while protecting public budgets from runaway costs. The U.S., by contrast, historically lacked a mechanism for the federal government to negotiate prices for most drugs, though that has begun to change in limited ways.
Where the U.S. Spends Differently
The U.S. spends roughly twice as much per person on healthcare as other high-income countries, yet Americans use healthcare services at similar rates. The gap isn’t driven by people getting more care. It’s driven by higher prices for labor and goods, higher pharmaceutical costs, and significantly higher administrative overhead.
Administrative costs, meaning the money spent on planning, regulating, billing, and managing the system rather than delivering care, consume about 8% of total U.S. health spending. In other high-income countries, that figure ranges from 1% to 3%. The complexity of the American system, with its patchwork of private insurers, employer plans, government programs, and uninsured patients, requires enormous resources just to process claims, verify coverage, and handle billing disputes. Every doctor’s office needs staff dedicated to navigating different insurance requirements. Every hospital maintains departments focused on collections and prior authorizations.
The U.S. system is itself a hybrid that already contains elements of universal coverage. Medicare functions as a single-payer system for adults 65 and older. The Department of Veterans Affairs operates as socialized medicine, where the government both pays for and directly provides care. Medicaid covers low-income populations. Employer-sponsored insurance is subsidized through tax breaks. These pieces exist alongside a private insurance market and a significant population that remains uninsured or underinsured. The result is a system where no single entity has the bargaining power or administrative simplicity that universal systems enjoy.
The Trade-Offs Other Countries Accept
Universal systems aren’t without costs beyond taxes. Wait times for non-emergency procedures are a common trade-off in countries like Canada and the UK, where demand for specialists or elective surgeries can exceed capacity. Patients in Germany’s statutory system may find that private insurance holders get faster appointments. And in every universal system, governments face constant pressure to control spending as populations age and new treatments get more expensive.
The UK’s health budget has nearly doubled as a share of total government spending since the late 1970s, rising from 9.4% to 18.3% in 2022-23. That growth creates political tension over funding levels, staffing, and service quality. Countries with payroll-based systems like Germany face a different pressure: as wages stagnate or employment shifts toward part-time and gig work, the revenue base can erode.
Technology helps offset some of these challenges. Taiwan’s single-payer system, for example, issues every enrollee a smart card with an embedded chip storing records from the last six medical visits, catastrophic illness information, test results, and medication history. This system, in place since 2004, reduces duplicated tests, prevents dangerous drug interactions, and keeps administrative costs remarkably low.
Why the U.S. Hasn’t Made the Same Choice
The question of why healthcare is “free” elsewhere is ultimately a question about political choices, not economics. Every wealthy country can afford universal coverage. The U.S. already spends more public money per capita on healthcare than most nations with universal systems. The difference is in how that money flows and who controls it.
Countries that built universal systems typically did so in moments of political consensus, often after World War II, when rebuilding societies made collective healthcare a priority. The U.S. developed its employer-based insurance system during the same era, partly as a workaround for wartime wage controls, and private insurers became deeply embedded in the economy. Today, the health insurance industry, pharmaceutical companies, hospital systems, and employer benefit structures all have financial stakes in the current arrangement, creating political resistance to fundamental restructuring that doesn’t exist in countries where universal coverage is already the status quo.